Louisiana 2018 Regular Session

Louisiana House Bill HB827

Introduced
4/3/18  
Introduced
4/3/18  
Refer
4/4/18  

Caption

Extends the termination date of law authorizing recommendation or prescription of medical marijuana

Impact

The extension of the termination date is significant as it underscores the legislature's commitment to maintaining and possibly enhancing the therapeutic options available to patients. By allowing medical professionals to prescribe and recommend medical marijuana for a longer period, the state policy aligns more closely with evolving medical perspectives on cannabis as a treatment for various ailments. This move is expected to support broader access to medical marijuana, thereby impacting healthcare and pharmaceutical regulations in the state.

Summary

House Bill 827 amends Louisiana's existing medical marijuana legislation by extending the termination date for prescribing and recommending medical marijuana from January 1, 2020, to January 1, 2025. This modification reflects ongoing support for the therapeutic use of medical marijuana, which has gained traction among healthcare professionals and patients alike. The bill aims to ensure that patients continue to have access to medical marijuana for their health conditions without interruption from legislative turnover.

Sentiment

The sentiment around HB 827 is largely positive among advocates for medical marijuana, including patient groups, healthcare providers, and dispensaries. Supporters argue that extending the authorization is a necessary step to offer patients relief and incorporate medical marijuana into their treatment plans. However, there are also concerns about the appropriate use of medical marijuana and the need for continued oversight to prevent misuse. The dialogue suggests an ongoing balancing act between providing access to medical care and maintaining regulatory integrity.

Contention

While there is considerable support for the bill, debates may arise regarding the implications of long-term marijuana use in therapeutic settings, including concerns over addiction, effectiveness, and regulation. Notable points of contention could include calls for stricter monitoring and guidelines on prescriptions to prevent potential misuse of medical marijuana. The conversation around HB 827 reflects the broader discussions in society regarding the transitioning legal landscape for marijuana use and its regulation at both the state and federal levels.

Companion Bills

No companion bills found.

Previously Filed As

LA HB823

Extends the termination date of laws authorizing the recommendation or prescription of medical marijuana in the treatment of certain debilitating medical conditions

LA HB627

Authorizes the recommendation of medical marijuana for treating certain health conditions of persons with autism

LA HB793

Provides relative to nurse practitioners and medical marijuana prescriptions

LA HB579

Provides relative to the authorization for therapeutic use of marijuana

LA HB391

Authorizes the recommendation of medical marijuana in raw or crude form and limits the dispensing of such product

LA HB819

Authorizes the recommendation of medical marijuana for additional conditions and allows any state-licensed physician to recommend medical marijuana

LA HB351

Provides relative to a recommendation of medical marijuana in employment

LA HB376

Provides relative to the regulation of medical marijuana

LA SB271

Provides for medical marijuana. (See Act) (RE1 SEE FISC NOTE GF EX See Note)

LA HB158

Authorizes the recommendation of medical marijuana in treating certain neurodegenerative diseases and conditions

Similar Bills

HI SB704

Relating To Marijuana.

AZ HB2082

Marijuana; sampling; advertising; sale

AZ HB2770

Marijuana; interstate agreements; delivery

CT HB05458

An Act Concerning The Regulation Of The Retail Sale Of Marijuana.

AZ SB1410

Marijuana; licensing; delivery

HI HB7

Relating To Marijuana.

VA HB2428

Marijuana; advertising restrictions, penalties.

VA SB1233

Marijuana; advertising restrictions, penalties.